An aid in stimulating active immunisation of 1 day old chicks against Marek’s Disease.
1000 / 2000 doses live cell-associated Chicken Herpesvirus 301/B1 (Serotype 2) and Turkey Herpesvirus (Serotype 3) vaccine per glass ampoule.
The glass ampoules are held in metal canes stored in liquid nitrogen.
Each metal cane holds 5 glass ampoules.
200 ml / 400 ml Sterile Diluent
Live attenuated Marek’s Disease vaccine is given to 1 day old chicks.
At 1 day-of-age administer 0.2 ml VVMD-Vac by subcutaneous injection.
The vaccine must be transported and stored submerged in liquid nitrogen at -196°C at all times until thawed for reconstitution.
Take care when withdrawing a metal cane of ampoules from the liquid nitrogen and wear protective clothing.
Occasionally glass ampoules may explode when removed from the liquid nitrogen or metal cane, or when placed in the thawing container.
Reconstituted vaccine must be held at less than 27°C and used within 2 hours.
In accordance with the World Organization for Animal Health (OIE) best practice, all susceptible birds should be vaccinated concurrently with the dose recommended by the manufacturer.
Avoid exposing chicks to early challenge by field strains of Marek’s disease virus. Place chicks into a clean environment not contaminated by adult chickens. This enables the vaccinated chicks to develop immunity before being challenged by field strains of Marek’s disease virus.
Vaccination prevents clinical manifestations of Marek’s disease, but does not prevent infection by and shedding of field strains of Marek’s disease virus.
See VVMD-Vac package insert for detailed directions for use.
VVMD-Vac registered pursuant to the ACVM Act 1997, No. A6751. See www.foodsafety.govt.nz for registration conditions.
Marek's Disease Technical Summary
Administration Information Sheet
Product Information Sheet